Biocept (BIOC) is heading in the right direction
Biocept Inc (BIOC) currently trades at $0.28 and has grown by 5.62% today. Over the past 3 years, Biocept stock has been punished to the tune of a mighty 99.50% decline. To no one’s surprise the stock is extremely cheap. But some analyst believes the oncology diagnostics company is heading in the right direction.
Based on this information, investorsQ rates this stock 5 out of 10. We give it this rating based on current information. The analyst notes Biocept’s growth. Last week, the company released its 4Q19 earnings report with sales of $1.8 million in the quarter indicating year-over-year growth of 108% and an increase of 17% from the prior quarter. The high forecast for Biocept Inc is $1.00 and the low is $0.05. Notably, the company’s market cap is $30.31 million with a 52 week high of $2.11 and a 52 week low of $0.21.